VEGFR TKI 'resistance' or transient clinical insensitivity to VEGFR TKI in metastatic renal cell carcinoma.
Ravaud
A
A
Department of Medical Oncology, Hôpital Saint André, Bordeaux University Hospital, CHU Bordeaux; Bordeaux University Hospital, Victor Segalen; Clinical Investigational Center, INSERM 005, Bordeaux, France. Electronic address: alain.ravaud@chu-bordeaux.fr.
Digue
L
L
Department of Medical Oncology, Hôpital Saint André, Bordeaux University Hospital, CHU Bordeaux; Clinical Investigational Center, INSERM 005, Bordeaux, France.
Trufflandier
N
N
Department of Medical Oncology, Hôpital Saint André, Bordeaux University Hospital, CHU Bordeaux.
Smith
D
D
Department of Medical Oncology, Hôpital Saint André, Bordeaux University Hospital, CHU Bordeaux; Clinical Investigational Center, INSERM 005, Bordeaux, France.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000008:administration & dosage / Q000009:adverse effects; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D004334:Drug Administration Schedule; D019008:Drug Resistance, Neoplasm / Q000502:physiology*; D006801:Humans; D007211:Indoles / Q000008:administration & dosage; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects; D011758:Pyrroles / Q000008:administration & dosage; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors*; D000077157:Sorafenib; D000077210:Sunitinib; D013997:Time Factors
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D007211:Indoles; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D011758:Pyrroles; D009536:Niacinamide; D000077157:Sorafenib; D040262:Receptors, Vascular Endothelial Growth Factor; D000077210:Sunitinib